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Abstract
Background: Until recently, the corpus luteum (CL) was considered to be the main source of progesterone (P4)
during pregnancy in the domestic cat (Felis catus). However, other possible sources of P4 have not been ruled out.
Although feline placental homogenates were found to be capable of synthesizing P4, expression of the respective
steroidogenic enzymes has not been investigated at the molecular level. Therefore, in the present study, expression
of the two major factors involved in the synthesis of P4 - 3beta-hydroxysteroid dehydrogenase (3betaHSD) and
steroidogenic acute regulatory protein (StAR) - was investigated in the feline CL and placenta during the course
of pseudopregnancy and pregnancy.
Methods: The mRNA levels of StAR and 3betaHSD were determined using Real Time PCR and their localizations
were determined by immunohistochemistry. Placental P4 concentrations, after ethyl extraction, were measured
by EIA.
Results: Luteal 3betaHSD and StAR mRNA levels were strongly time-dependent, peaking during mid-pregnancy.
The placental 3betaHSD mRNA level was significantly upregulated towards the end of pregnancy. In the CL,
3betaHSD and StAR protein were localized in the luteal cells whereas in the placenta they were localized to the
maternal decidual cells. Placental P4 concentrations were low in early pregnant queens, but increased along
with gestational age.
Conclusions: These results confirm that the placenta is an additional source of P4 in pregnant queens and can
thereby be considered as an important endocrine organ supporting feline pregnancy.
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Background
Female domestic cats (Felis catus) are traditionally clas-
sified as seasonally polyestrous with ovulation provoked
by coitus [1,2]. However, in as many as 50% of domestic
cats, ovulation occurs without cervical or vaginal stimu-
lation [3,4]. If ovulation is not followed by pregnancy,
the queen enters pseudopregnancy during which the
corpora lutea (CL) remain active. Hence, the reproduct-
ive cycle in the domestic cat differs significantly from
that in ungulates [5,6] and dogs [7,8], in which spontan-
eous ovulation is followed by the formation of CL in
each estrous cycle. In the cat [9], rabbit [10] and rat
[11], the luteal phase of non-pregnant animals lasts only
one-half of a normal gestation. This means elevated pro-
gesterone (P4) levels measured in circulating blood for
35–40 days in pseudopregnant and for approximately
60–65 days in pregnant queens. In contrast, in the dog
[12], mink [13] and ferret [14], the length of the luteal
phase is similar in the presence or absence of pregnancy.
Progesterone levels in pregnant and non-pregnant dogs
are similar within the first 60 days after ovulation [15].
Moreover, there are no indications of an active luteolytic
principle in non-pregnant dogs, and, the canine CL
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appears to be devoid of PGF2α-synthase (PGFS) activity
[16,17]. Consequently, luteal regression in non-pregnant
bitches seems to be a passive degenerative process in the
absence of endogenous PGF2α [16,17]. The domestic
cat thus seems to have a reproductive advantage over
some other carnivores because its shorter luteal phase
allows for an earlier return to estrual cyclicity. In the
cat, ovarian activity returns within 7 to 10 days following
pseudopregnancy [10]. The histological and endocrine
patterns of early CL formation are the same in pregnant
and pseudopregnant cats until days 10–12 after coitus
[18]. However, after days 12–13, which coincides with
the time of implantation [19,20], plasma P4 concen-
tration slowly declines in pseudopregnant queens,
whereas during pregnancy it remains on a plateau until
day 30 and then gradually declines towards the end of
gestation [21].
Until the 1970s, the CL was considered to be the main
source of P4 during feline gestation. However, the
finding that ovariectomy in queens after day 45 either
did not interrupt pregnancy [22] or only did in some
animals [23] supported an assumption that the placenta
is a source of steroidogenic enzymes [18]. Subsequently,
feline placental homogenates were found to be capable
of synthesizing P4 [19]; however, the expression of
steroidogenic factors or P4 content has not been
examined in the placenta to date.
Cholesterol is the precursor of all steroid hormones.
Steroidogenesis is regulated by steroidogenic acute
regulatory (StAR) protein, which controls cholesterol
transport from the outer to the inner mitochondrial
membranes of the steroidogenic cells [24]. Conversion
of pregnenolone to P4 is a step catalyzed by 3β- hydro-
xysteroid dehydrogenase/isomerase (3βHSD). In this
study, expression of these two factors was investigated
in the feline CL and placenta throughout pregnancy
and pseudopregnancy.
Methods
Animals and tissue preservation
All procedures were approved by the Local Animal Care
and Use Committee in Olsztyn, Poland (No. 41/2007/N
and 61/2010/DTN).
Privately owned queens (n = 36, mixed breed, proven
health status), aged 18 ± 5 months, housed individually
or in pairs, with or without contact with an intact male,
were enrolled in this study. No pharmacological treat-
ment was performed to provoke ovulation in the ani-
mals. In the case of pregnant queens, an ovulation was
provoked with coitus. Queens were checked daily for
behavioral signs of estrus (treading of the hind feet, lor-
dosis and tail deflection). The first day of silencing of
estrus behavior in the queens was considered as Day 1
of the luteal phase. Reproductive tracts were collected
from 13 pseudopregnant cats at early (n = 4, days 3–5),
mid (n = 4, days 10–15) and late phases of pseudopreg-
nancy (n = 5, days 25–35), and from 12 pregnant cats at
early (n = 5), mid (n = 4) and late (n = 3) gestation: 1.5-2,
3–4 and 6–8 weeks after mating, respectively. For
extraction of P4 from placentas, an additional 11 cats at
different gestational ages were subjected to ovariohyster-
ectomy (OHE), which was done with the owners’ request
and consent. The stage of the estrous cycle was fur-
ther confirmed by endocrine analysis, according to the
P4 values reported in the literature [10,25], and macro-
scopic observation of the ovaries and uterus. Before sur-
gery, blood samples were collected from the cephalic
vein into EDTA-containing tubes (Tyco Healthcare
Group LP, Mansfield, USA) and transported to the
laboratory at 4°C. Plasma obtained after blood centrifu-
gation (3500 x g, 10 min) was frozen at −20°C until P4
measurement using direct enzyme immunoassay (EIA).
Confirmation of gestational age was done according
to the P4 values reported in the literature [18]. In
addition, measurements of the crown-rump length in
fetuses and uterine ampullae diameter or length were
performed [26,27].
Tissues were washed immediately after surgery with
sterile saline to remove blood contamination, then
placed into fresh sterile saline at 4°C and transported to
the laboratory within 1 h. The CL were removed from a
randomly selected ovary among the pairs belonging
to the same luteal stage. The second ovary was fixed in
buffered 4% formaldehyde for 24 h, dehydrated and
wax-embedded. Sections (2–3 μm thick) were used for
evaluation of protein concentrations by immunohisto-
chemistry. In pregnant animals, uterine horns were
slit longitudinally and fragments of placenta were sepa-
rated, washed in fresh saline to remove blood, preserved
overnight at 4°C with RNAlater (Ambion Biotechnologie
GmbH, Wiesbaden, Germany), and then stored at −80°C
until total-RNA extraction. mRNA levels were determined
using Real Time PCR, while localization of 3βHSD and
StAR protein was examined by immunohistochemistry.
Cloning of feline 3βHSD by reverse transcription (RT) and
rapid amplification of cDNA ends polymerase chain
reaction (RACE PCR)
Total RNA was isolated from feline CL using Trizol
Reagent according to the manufacturer’s instructions
(Gibco-BRL, Life Technologies, Karlsruhe, Germany).
The whole procedure was carried out as described
before for canine 3βHSD [28]. For initial RT-PCR, 0.2 μg
of total RNA was used. An alignment of the known
canine 3βHSD sequence (GenBank accession number:
AY739720) against the available online feline genomic
sequence [29] was performed using BLASTW software
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to obtain feline-specific PCR product (primers 1–2;
Table 1). Integrity of RNA was checked by amplification
of the housekeeping gene β-actin (primers 3–4, Table 1).
First strand cDNA synthesis was performed with the
PowerScript Reverse Transcriptase kit (BD Biosciences
Clontech GmbH, Heidelberg, Germany) using 0.6 μg of
total RNA. Subsequently, the SMART RACE cDNA
Amplification kit (BD Biosciences Clontech GmbH) was
used with gene-specific primers (GSP, primers 5–6;
Table 1) in combination with universal primer mix
(UPM, primers 7–8; Table 1) supplied by the manufac-
turer of the SMART RACE Kit. Overlapping products of
the missing cDNA coding fragments of the 50 and 30
ends were amplified. After initial denaturation at 94°C
for 1 min, the reactions were run for 35 cycles (94°C for
1 min, annealing at 65°C for 2 min, elongation at 72°C
for 3 min), and the final extension was at 72°C for
10 min. Finally, RT-PCR for 40 cycles was performed at
an annealing temperature of 57°C with specific primers
(primers 9–10; Table 1) located at both ends of the
open reading frame (ORF). All PCR products were
visualized on a 1.5% ethidium bromide-stained gel, puri-
fied with a Qiaex II agarose gel extraction kit (Qiagen
GmbH, Hilden, Germany), ligated into pGEM-T vector
(Promega, Dübendorf, Switzerland), multiplied in XL1
BLUE competent cells (Stratagene, La Jolla, CA, USA)
and sequenced (Microsynth, Balgach, Switzerland).
Finally, the cloned cDNA sequence was submitted to
GenBank with the accession number: JF794032, Felis catus
3β-hydroxysteroid dehydrogenase mRNA, complete cds.
Cloning of feline StAR cDNA
The procedure leading to characterization of feline StAR
protein was carried out as previously described for ca-
nine StAR protein [30]. Total RNA was obtained from
three feline CLs collected at early, mid and late phases
of pseudopregnancy. The DNase- treatment was per-
formed with RQ1 RNase free DNase (Promega), and the
RT-PCR was done with the GeneAmp Gold RNA PCR
kit (Perkin-Elmer Applied Biosystems GmbH, Weiter-
stadt, Germany), all as previously described [30]. Primers
for qualitative PCR were obtained from the alignment of
the canine sequence with GenBank accession number
EF522840 using an online available feline genomic
sequence. Using primer pairs (13–14; Table 1), a PCR
product comprising 886 bp of feline StAR protein was
amplified. PCR conditions were as follows: initial
denaturation at 95°C for 10 min, then reactions were
run for 40 cycles consisting of denaturation at 94°C for
1 min, annealing at 56°C for 1.5 min and elongation at
72°C for 1.5 min; the final extension was at 72°C
for 10 min. PCR products were visualized on a 1.5% eth-
idium bromide-stained gel, purified with the Qiaex II
agarose gel extraction kit (Qiagen GmbH, Hilden,
Germany), ligated into the pGEM-T vector (Promega)
multiplied in XL1 BLUE competent cells (Stratagene,
Table 1 List of primers used for RT-PCR, RACE PCR and Real Time PCR
Primer no. Gene Primer sequences Accession number
1. Initial 3βHSD for RT-PCR FWD 50-TTGATACCCCGGTTTGACCA −30 AY739720
2. Initial 3βHSD for RT-PCR REV 50-TTGGCACCCCTAGATCAGTG −30
3. ACTB for RT-PCR FWD 50-ATCAAGGAGAAGCTGTGCTACGT-30 AB51104
4. ACTB or RT-PCR REV 50-CGTTGCCGATGGTGATCA −30
5. 3βHSD RACE PCR GSP FWD 50-CACCAAAGCTATGATAACCTCAAT −30 AY739720
6. 3βHSD RACE PCR GSP REV 50-AGGCAAGCCAGTACTCCAGAAAT −30
7. Universal Primer Mix (UPM) FWD 50-CTAATACGACTCACTATAGGGCAAGCAG -
TGGTATCAACGCAGAGT-30
8. UPM REV 50-CTAATACGACTCACTATAGGGC-30 AY739720
9. 3βHSD for RT-PCR (ORF) FWD 50-TTGATACCCCGGTTTGACCA −30
10. 3βHSD for RT-PCR (ORF) REV 50-TTGGCACCCCTAGATCAGTG −30 JF794032
11. 3βHSD specific for Real Time PCR FWD 50-TCCCCAGTGTTTCTGATTCC −30
12. 3βHSD specific for Real Time PCR REV 50-CACCAACAAATGCACGATTC −30 EF522840
13. Initial StAR for RT-PCR FWD 50-CAATGCTCCTAGCGACGTTC −30
14. Initial StAR for RT-PCR REV 50-AACAGTTGGAAGCAGCAGG −30
15. StAR for Real Time PCR FWD 50-CCCATGGAGAGGCTTTATGA-30 JF800676
16. StAR for Real Time PCR REV 50-CAACTCGTGGGTGATGACTG −30
17. Cyclophilin for Real Time PCR FWD 50-CCTTCTGTAGCTCGGGTGAG −30 AY029366
18. Cyclophilin For Real Time PCR REV 50-CTTGGAGGGGAGGTAAGGAG −30
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La Jolla, CA, USA) and sequenced (Microsynth, Balgach,
Switzerland). The cloned cDNA sequence was submitted
to GenBank with the accession number JF800676 (Felis
catus Steroidogenic Acute Regulatory protein (StAR)
mRNA cds).
Real Time PCR
The levels of mRNA expression of target genes were
examined by Real-Time PCR using specific primers for
3βHSD, StAR and cyclophilin (Cyc). Among several dif-
ferent genes, including β-Actin, GAPDH and Cyc, the
last one was employed as a reference because the differ-
ences in Cyc expression between different samples did
not exceed two cycles. All primers were purchased from
Microsynth (Balgach, Switzerland). The forward and re-
verse sequences used for quantitative Real-Time PCR
and the GenBank accession numbers are given in Table 1
(primers 11–12, 15–16 and 17–18). The Real-Time PCR
reactions were carried out in an automated fluorometer
ABI PRISMW 7300 Sequence Detection System (Applied
Biosystems, Darmstadt, Germany) using SYBR Green
Master Mix (Applied Biosystems, Applera, Warsaw, Pol-
and). PCR reactions were performed in 96-well plates.
The total reaction volume was 20 μl containing: 1 μl
cDNA (200 ng), 250 nM each of forward and reverse
primers, and 10 μl SYBR Green PCR Master Mix. Real
time PCR was carried out as follows: initial denaturation
(10 min at 95°C), followed by 40 cycles of denaturation
(15 s at 95°C) and annealing (1 min at 60°C). After each
PCR reaction, melting curves were obtained by stepwise
increases in temperature from 60 to 95°C to ensure sin-
gle product amplification. The presence of the product
was also confirmed by electrophoresis on 2% agarose
gel. Relative quantification was performed by normaliz-
ing the signals of target genes with the Cyc signal by the
Miner method for quantifying qRT-PCR results using
calculations based on the kinetics of individual PCR
reactions [31].
Immunohistochemistry
Immunohistochemistry was done according to the pro-
cedure described by Kowalewski et al. [30]. Firstly, the
sections were deparaffinized and rehydrated, and then
incubated in citrate buffer (10 nM, pH 6.0) for 15 min
under microwave irradiation at 560 W for antigen
retrieval. After cooling for 20 min at 20°C, sections
were incubated in 0.3% H2O2 in methanol for 30 min
to quench endogenous peroxidase and then washed
in IHC-buffer/0.3% Triton X pH 7.2-7.4 (0.8 mM
Na2HPO4, 1.47 mM KH2PO4, 2.68 mM KCl, 1.37 mM
NaCl). To block nonspecific binding sites, sections were
incubated in 10% goat or horse serum. The first primary
antibody (dilution 1:5000) was a rabbit polyclonal anti-
serum against human placental 3βHSD that was kindly
donated by Dr I.J. Mason (Clinical Biochemistry, Centre
for Reproductive Biology, University of Edinburgh)
[32]. The second primary antibody (dilution 1:3000) was
a rabbit polyclonal antibody against StAR protein.
This was an antipeptide antiserum against amino acids
88–98 of mouse StAR protein kindly donated by
Dr. Douglas M. Stocco (Texas Tech University Health
Sciences Center, Lubbock, US) [33]. Serum from a non-
immunized rabbit served as an isotype control. The third
primary antibody (dilution 1:100) was a mouse monoclo-
nal anti-vimentin clone 3B4 (DakoCytomation, Glostrup,
Denmark). Vimentin was used to identify cells of mesen-
chymal origin (e.g., maternal decidual cells, fibroblasts
or blood vessels) and distinguish them from non-
mesenchymal cells such as fetal trophoblast cells, in the
placenta [34]. Sections were incubated overnight at 4°C,
then washed in IHC-buffer and incubated with biotiny-
lated goat IgG (secondary antibody, dilution 1:100)
against rabbit immunoglobulin (Vector Laboratories,
Burlingame, US) (used as a secondary antibody for the
sections stained against StAR and 3βHSD) or biotiny-
lated horse IgG (secondary antibody, dilution 1:200)
against mouse immunoglobulin (Vector Laboratories,
Burlingame, US) (used as a secondary antibody for the
sections stained against vimentin). Then the sections
were incubated with the avidin-biotin-peroxidase
complex (Vectastain ABC kit, Vector Laboratories,
Burlingame, US) for 30 min at 20°C. After washing
with IHC-buffer, sections were allowed to react with the
substrate diamino-benzidine (DAB; DakoCytomation,
Glostrup, Denmark) according to the manufacturer’s
instructions. The reactions were arrested by dipping the
sections under running tap water for 5 min. Hematoxylin
was used to counterstain the sections, then they were
mounted in Histokit (Assistant, Osterode, Germany).
Isotype control was done to avoid false positive results.
The luteal and placental sections were incubated with
serial dilutions of pre-immunized rabbit serum (starting
at 1:1000) or pre-immunized mouse serum (starting
at 1:50). No positive staining was observed at a 1:3000
dilution of pre-immunized rabbit serum or at a 1:100
dilution of pre-immunized mouse serum.
Placental progesterone extraction
Progesterone extraction was carried out using a modifi-
cation of a methoddescribed previously [35]. Placenta
samples were stored at −80°C. The tissues (200–300 mg
each) were thawed and homogenized in glass vials using
a tissue disruptor with 400 μl EIA buffer containing
45 μl 1 N HCl. Next, 3 ml of ethyl petroleum was added
to each sampleand it was shaken for 10 min, then
samples were incubated at −20°C for 4 h. Afterwards,
the supernatant was collected and evaporated to dryness
under nitrogen at 40°C. Finally, 400 μl of EIA buffer with
Siemieniuch et al. Reproductive Biology and Endocrinology 2012, 10:89 Page 4 of 10
http://www.rbej.com/content/10/1/89
0.1% BSA was added. The suspension was frozen at
−20°C until P4 measurement by EIA.
Progesterone determination
Assessment of P4 concentration in plasma followed
the methodology previously described [36]. Horseradish
peroxidase-labeled P4 was used at a final dilution of
1:75.000. Anti-P4 serum (final dilution of 1:100 000) was
kindly donated by Dr. Stanisław Okrasa, University of
Warmia and Mazury, Olsztyn, Poland. The ED50 for P4
was 4.2 ng/mL and the assay ranged from 0.39 to
100 ng/mL. The intra- and inter-assay CVs were 4.2%
and 9.3%, respectively. Progesterone concentration in
plasma was expressed as ng per mL (ng/mL) and in
placenta as ng per g (ng/g).
Statistics
To test the effect of different stages of pregnancy or
pseudopregnancy on mRNA levels, the Kruskal-Wallis Test
(a nonparametric ANOVA) was used followed by the
Newman-Keuls Multiple Comparison Test using the statis-
tical software program GraphPad5 (GraphPad PRISM
v 5.0; GraphPad Software Inc., San Diego, CA, USA).
Progesterone concentrations in plasma are shown as a
mean ± standard deviation. To test the effect of the pres-
ence or absence of pregnancy on circulating P4 concentra-
tions within each luteal phase, a nonparametric ANOVA
was used followed by the Newman-Keuls Multiple Com-
parison Test. Significance was defined as values of P < 0.05.
Results
Determination of pregnancy or pseudopregnancy stages
Queens were considered to be at the early luteal phase
when the plasma P4 was between 2 to 8 ng/mL and
Figure 2 Progesterone values in blood and placenta. Progesterone values in blood (upper part) and placenta (lower part) in cats
ovariectomized at different weeks of pregnancy.
Figure 1 Progesterone values in blood of queens at early, mid
and late pseudopregnancy or early, mid and late pregnancy.
Letters “a, b” indicate statistical differences among groups. Asterisks
indicate statistical differences in P4 levels between groups within
pregnancy or pseudopregnancy conditions (*P < 0.05, **P < 0.01).
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the corpora haemorrhagica were ≥ 2 mm in diameter.
Mid-pseudopregnancy was determined when plasma P4
was > 17 ng/mL and CL were reddish and 3–4 mm
in diameter. Late pseudopregnancy was characterized by
plasma P4 < 5 ng/mL and the presence of pale CL. The
queens were considered to be at early, mid and late preg-
nancy when the plasma P4 was between 2 to 8, > 20 or <
12 ng/mL, respectively. Progesterone concentrations in
plasma are shown in Figure 1. The serum P4 con-
centration was 3.9 ± 1.4 ng/mL, 39.9 ± 32.2 ng/mL and
4.2 ± 1.2 ng/mL in queens at early, mid and late pseu-
dopregnancy, respectively; and 5.4 ± 2.3 ng/mL, 46.5 ±
19.6 ng/mL and 5.3 ± 6.4 ng/mL in queens at early,
mid and late pregnancy, respectively. No statistical differ-
ences were seen within each luteal phase examined with
respect to the presence or absence of pregnancy (P > 0.05).
Placental P4 contents depended on the gestational age and
are shown in Figure 2. The amount of extracted P4 was
1.7 ± 0.77 ng/g, 5.5 ± 0.58 ng/g and 8.7 ± 3.01 ng/g of tis-
sue from early, mid and late pregnant queens, respectively.
StAR- and 3βHSD- mRNA levels in the feline CL and placenta
Luteal StAR mRNA was strongly time-dependent,
with significantly elevated mRNA-levels observed during
mid-pregnancy (P < 0.001) (Figure 3). No statistically
significant changes were observed among placental
StAR-mRNAs detected at early, mid and late gestation
(Figure 3).
Luteal 3βHSD mRNA expression was also strongly
time-dependent, with significantly elevated mRNA levels
observed during mid-pseudopregnancy (P < 0.05) and
mid-pregnancy (P < 0.01) (Figure 4). Placental 3βHSD-
mRNA was significantly up-regulated towards the end of
pregnancy (P < 0.01) (Figure 4).
Localization of StAR protein and 3βHSD in the feline CL
and placenta
The spatial localizations of StAR and 3βHSD proteins in
the gestational CL and placenta are shown in Figures 5
and 6, respectively. Within the CL, StAR and 3βHSD
protein were localized in the luteal cells (Figure 5A and
5B, respectively). Immunostaining against StAR protein
and 3βHSD was observed in early, mid and late pseudo-
pregnancy CL, as well as in early, mid and late preg-
nancy CL. Based on comparison with the pattern of
staining with vimentin (Figure 6B), the placental cells in
which StAR (Figure 6C) protein and 3βHSD (Figure 6D)
were immunolocalized were identified as cells of
Figure 3 StAR mRNA transcription. StAR mRNA transcription in
pseudopregnant and pregnant CLs (upper panel) and placenta
(lower panel). Letter “a” indicates no statistical differences within
pseudopregnancy. Letters “x, y” indicate statistical differences within
pregnancy (P < 0.001). Asterisks indicate statistical differences
between StAR mRNA levels during the course of pseudopregnancy
and pregnancy (***P < 0.001).
Figure 4 3β-HSD-mRNA expression in pseudopregnant and
pregnant CLs (upper panel) and placentas (lower panel).
Letters “a, b” indicate statistical differences within pseudopregnancy
(P < 0.05). Letters “x, y” indicate statistical differences within
pregnancy (P < 0.01). Asterisks indicate statistical differences between
3β-HSD-mRNA levels during the course of pseudopregnancy and
pregnancy (***P < 0.001).
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mesenchymal origin such as maternal decidual cells
(Figure 6B). Positive staining against both proteins
examined was generally observed in mid and late
pregnancy placentas. A slight positive staining against
3βHSD was also observed in the fetal component of
the placentas.
Discussion
The present results confirm that the placenta is an add-
itional source of P4 in pregnant queens, possibly acting
as an important endocrine organ during pregnancy. Both
StAR and 3βHSD were immunolocalized in the placenta
and CL in each luteal phase. In the present study, the lu-
teal 3βHSD mRNA expression patterns in pregnant
and pseudopregnant animals were similar, both peaking
during the mid-luteal phase. However, luteal mRNA
was 2.5-fold higher in pregnant than in pseudopregn-
ant queens. Luteal StAR mRNA remained at a relatively
constant low level in pseudopregnant animals, but fol-
lowed the pattern of 3βHSD mRNA expression in preg-
nant animals. However, no quantitative assessment was
performed for the expression of StAR and 3βHSD at the
protein level.
A rapid development of the P4-producing CL is
observed in both pregnant and pseudopregnant cats.
Plasma P4 levels are about the same in pregnant and
pseudopregnant queens in the first 10–12 days after co-
itus [18] but their profiles diverge as early as on day 12
or day 13 after coitus, which is the period of implant-
ation in the cat [18,20]. The luteal StAR- and 3βHSD-
mRNA were highest during the mid-phase of pregnancy.
Additionally, increased 3βHSD-levels were also observed
at the mid-phase of pseudopregnancy. The high expres-
sion of both factors during both mid-luteal phases may
be responsible for the strongly elevated P4 levels in the
circulating blood reported previously [2,18,21,37] and
observed also in the present study. As reported previ-
ously, P4 values rose rapidly in pseudopregnant queens
between Day 4 and Day 9, peaking around Day 14 post-
ovulation with a plateau between Day 9 and Day 23. The
range of serum P4 concentrations at that time was
30 ng/mL to more than 87 ng/mL [2]. The present
results concur with data reported earlier, in which strong
individual variations in plasma P4 concentrations were
observed. In one queen experiencing a nongravid luteal
phase, P4 peaked at 88 ng/mL, vs. a range of 20.1-
28.7 ng/mL observed in other animals. The mean value
of plasma P4 observed in queens at the mid-luteal stage
was 39.9 ng/mL and is consistent with the those
reported in the literature [2]. However, in another study,
P4 values in pseudopregnant cats were shown to peak at
levels of 17 ng/mL on Day 18 postcoitum, followed by a
gradual decline to values < 1 ng/mL between Days 30–46
after coitus [25]. In pseudopregnant queens at the late
luteal stage, we usually observed distinctly diminished
P4 values compared to the mid luteal phase. Wildt and
coworkers [2] reported that the serum P4 values were
A) StAR B) 
C)
Figure 5 StAR (A) and 3βHSD (B) protein expression and negative control (C) in CL. Tissue collected at 8th week of pregnancy. Arrows
show luteal cells. Bar represents 100 μm.
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lower than 1 ng/mL by Day 42 post ovulation, however,
CL remnants were visually evident throughout the fol-
lowing interestrus period. In the present study, the P4
values in plasma reached approximately 4.2 ± 1.2 ng/mL.
However, blood samples were collected from pseu-
dopregnant queens only from Day 25 to Day 35 (Day 1
signified the first day of pseudopregnancy and was
consistent with silencing of estrus behavior), so this
difference might explain the discrepancy in observed
P4 values.
During mid-pregnancy, the serum P4 values varied
significantly between individual cats (range 34 –
74.4 ng/mL), with a mean P4 concentration of 46.5 ng/
mL. Although P4 concentrations in the blood of mid-
pregnant queens were numerically higher than in non-
pregnant animals in the mid-luteal phase, no statistical
differences were seen in the present study between these
two groups. It cannot be ruled out that these results
might differ significantly if the number of females in
each group were increased; however, it should also be
mentioned that the present data are very similar to those
reported by others (for review see: 2, 37). Distinct indi-
vidual variations in the plasma P4 levels collected from
pregnant cats were previously reported [37], i.e., peak
serum P4 from 13.5 to 57 ng/mL extending over Days 11
to 60 in individual females. After peripheral P4 peaked,
a gradual decline began, usually at Day 44 in most of
the queens that were examined. The P4 levels were
maintained at a relatively constant level until a few days
before parturition, when they sharply decreased [37]. In
B) VIM 
C) StAR D) 
E) Neg  
A) H/E 
Figure 6 Hematoxylin/eosin (A) staining and vimentin (B) protein expression, StAR (C) and 3βHSD (D) protein expression and negative
control (E) in placentas collected at the 8th week of pregnancy. Arrows show maternal decidual cells. Bar represents 50 μm in the Figure
showing staining for vimentin, StAR and 3βHSD or 100 μm in the Figure showing staining with hematoxylin/eosin and negative control.
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the present study, serum P4 decreasing to values lower
than 10 ng/mL (range 3.8 – 9.2 ng/mL) was observed in
queens in the 7th and 8th week of pregnancy; however,
in three individuals at the 6th and 7th week of pregnancy,
the P4 values were still near 30 ng/mL. Summarizing
these data, it might be concluded that, besides visible
differences existing in plasma P4 levels between indivi-
duals, the distinct decrease in peripheral P4 precedes
onset of parturition.
The successful extraction of P4 from the placenta
further supports its role as an additional source of P4
during pregnancy in the cat. Placental P4 concentrations
seem to be dependent on gestational age. Thus, the
higher P4 values reported for pregnant queens may
result from P4 supplementation by placental tissue, as
hypothesized previously [18]. Still remaining, however, is
the question whether the placenta-originating P4 would
be alone able to maintain pregnancy in domestic cats
ovariectomized after 45 days of pregnancy. In contrast
to cats, in mice it was proven that ovariectomy at any
time of pregnancy causes abortion [38]. It was thought
that P4 synthesis is not possible de novo in the rodent
placenta. Nevertheless, trophoblast giant cells from
mouse placenta were shown to produce P4 from choles-
terol [39]. Moreover, recent studies using molecular
tools have shown that P4 synthesis is possible in rodent
maternal decidual cells and occurs upon decidualization,
but is terminated at mid-gestation [40]. It is further
assumed that this local synthesis of P4 may act as an
immunosuppressive factor at the implantation sites [41].
In contrast in cows placenta-derived progesterone and
oestrone are supposed to be auto- or paracrine factors
involved in placental growth and differentiation [42].
The synthesis of P4 was recently demonstrated in uni-
nucleate trophoblast cells and the trophoblast giant
cells of the bovine placenta; however, these two kinds
of cells were reported to have different steroidogenic
capacities [43].
The morphological comparative study in the epithelio-
chorial and endotheliochorial placenta types published
by Leiser and coworkers in 1998 [44] presents a photo-
graph of the typical labyrinthine-like system in the cat
placenta with very easily visible and differentiated decid-
ual cells [44]. In the present study, anti-vimentin stain-
ing was applied in order to distinguish between cells of
mesenchymal origin and other sources, as described and
confirmed for the canine and feline placenta by Bezler
[34]. Since the StAR- and 3βHSD-positive placental cells
were identified as maternal decidual cells, and were
found mostly in placentas from the second half of gesta-
tion, the present findings on the spatio-temporal expres-
sion of the key steroidogenic genes differ from data
obtained for other species. Even though some 3βHSD-
positive cells were observed in the trophoblast, the
strongest signals were present in decidual cells suggest-
ing that these cells may be the main source of steroid
synthesis within the feline placenta. Although the repro-
ductive biology characteristics of the dog and cat are
often compared, especially on this point distinct differ-
ences are observed, because in dogs the CL is the only
source of P4 during both pseudopregnancy and preg-
nancy [7].
Conclusions
The cellular localization of the steroidogenic factors that
are present in the feline placenta differs from their loca-
lizations in rodents and cows. The present data confirm
previous observations that the feline placenta is a sup-
plemental source of P4 and could be important for the
maintenance of pregnancy in this species.
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